Ana Carolina Santos Ré

Mrs. Ana Carolina Santos Ré

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
GGGuilherme M Gelfuso
Guilherme M Gelfuso
RFRicardo Ferreira-Nunes
Ricardo Ferreira-Nunes
LDLuciana F. Dalmolin
Luciana F. Dalmolin
ARAna Carolina Santos Ré
Ana Carolina Santos Ré
GSGiselly A. dos Santos
Giselly A. dos Santos
TGTaís Gratieri
Taís Gratieri

17 April 2015 in Clinical Oral Investigations
Verified
Journal Article
Closed access
PDF file
RVRodrigo Alexandre Valério
Rodrigo Alexandre Valério
MBMaria Cristina Borsatto
Maria Cristina Borsatto
MSMonica Campos Serra
Monica Campos Serra
SPSilvana Aparecida Fernandes Polizeli
Silvana Aparecida Fernandes Polizeli
MNMariana Alencar Nemezio
Mariana Alencar Nemezio
SCSilmara Aparecida Milori Corona
Silmara Aparecida Milori Corona

10 May 2019 in Molecules
Verified
Journal Article
Open access
PDF file
EKErika R. H. Kawakita
Erika R. H. Kawakita
ARAna Carolina Santos Ré
Ana Carolina Santos Ré
MPMaria Paula G. Peixoto
Maria Paula G. Peixoto
MFMaíra Peres Ferreira
Maíra Peres Ferreira
ARAntônio P. Ricomini-Filho
Antônio P. Ricomini-Filho
CACarolina Aires
Carolina Aires
(1) Background: The effectiveness of chitosan to improve the action of antimicrobial compounds against planktonic bacteria and young biofilms has been widely investigated in Dentistry, where the biofilm lifecycle is a determining factor for the success of antibacterial treatment. In the present study, mature Streptococcus mutans biofilms were treated with chitosan dispersion (CD) or chitosan microparticles (CM). (2) Methods: CD at 0.25% and 1% were characterized by texture analysis, while CD at 2% was spray-dried to form CM, which were characterized with respect to particle size distribution, zeta potential, and morphology. After determining the minimum inhibitory and bactericidal concentrations, S. mutans biofilms were grown on glass slides exposed 8×/day to 10% sucrose and 2×/day to CD or CM at 0.25% and 1%. Biofilm viability and acidogenicity were determined, using appropriate control groups for each experiment. (3) Results: CD had high viscosity and CM were spherical, with narrow size distribution and positive zeta potential. CM affected bacterial viability and acidogenicity in mature S. mutans biofilms more strongly than CD, especially at 1%. (4) Conclusions: Both chitosan forms exerted antimicrobial effect against mature S. mutans biofilms. CM at 1% can reduce bacterial viability and acidogenicity more effectively than CD at 1%, and thereby be more effective to control the growth of mature biofilms in vitro.

19 February 2019 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
ARAna Carolina Santos Ré
Ana Carolina Santos Ré
MBMaria Carolina Bonjovanni
Maria Carolina Bonjovanni
MFMaíra Peres Ferreira
Maíra Peres Ferreira
OFOsvaldo Freitas
Osvaldo Freitas
CACarolina Aires
Carolina Aires
(1) Background: For any antibacterial oral formulation to be successful, it must present effects in the presence of biofilms. Therefore, our aim is to analyze the drug release and the antibiofilm effects of a semi-solid formulation containing chlorhexidine (CHX) in the presence of pathogenic biofilms. (2) Methods: The biofilms of Streptococcus mutans (n = 6) or Porphyromonas gingivalis (n = 3) were formed for 6 and 4 days, respectively, being exposed to: 1) a CHX system or 2) vehicle control without CHX. A group without treatment was included as negative control. The acidogenicity, CHX quantification and bacterial viability were determined. A dissolution assay in a buffer and culture medium in the absence of bacteria was also performed. (3) Results: Although the CHX quantification in the culture medium of both biofilms was lower compared to the buffer (p < 0.05) and the culture medium in the absence of bacteria, the CHX system was able to display antibiofilm effects until 96 h for the S. mutans biofilms (p < 0.05) and 72 h for the P. gingivalis biofilms (p < 0.05). (4) Conclusions: The experimental formulation is able to extend chlorhexidine effects, even in challenging conditions such as in the presence of bacteria, allowing the in vitro control of cariogenic biofilms for 4 days and periodontopathogenic biofilms for 3 days.

19 September 2016 in Biofouling
Verified
Journal Article
Closed access
ARAna Carolina Santos Ré
Ana Carolina Santos Ré
MFM. P. Ferreira
M. P. Ferreira
OFO. Freitas
O. Freitas
CACarolina Aires
Carolina Aires
The effect of a drug-delivery system containing antibacterial metronidazole (MDZ) prescribed for periodontitis on supragingival biofilm was evaluated, and possible interference by this biofilm in the drug release profile was investigated. Streptococcus mutans biofilms were grown and exposed to a controlled-release formulation of MDZ or the same formulation without MDZ (vehicle control). Untreated biofilms were used as a negative control (NC). Biofilms and culture medium (containing detached cells) were collected 24, 48, 72, and 96 h after first exposure to treatments. The biomass of the MDZ group was lower than that of the NC group at all times. Although MDZ yielded low drug-release rates in the presence of the biofilm, it was sufficient for reducing viability for 24 h and affecting bacterial metabolism for 48 h. These results suggest that MDZ appears to destabilize supragingival biofilm. This biofilm may interfere with MDZ release from the formulation.

1 November 2019
Verified
Journal Article
Closed access
ARAna Carolina Santos Ré
Ana Carolina Santos Ré
MFM. P. Ferreira
M. P. Ferreira
OFO. Freitas
O. Freitas
CACarolina Aires
Carolina Aires